Active Pharmaceutical Ingredient (API)
Remdesivir
Antiviral (Nucleotide Analog)
An intravenous antiviral nucleotide analog developed for treating SARS-CoV-2 (COVID-19) infection in hospitalized patients. It acts as a prodrug that interferes with viral RNA-dependent RNA polymerase, disrupting viral replication. Its rapid development and deployment highlighted its importance during the pandemic.
Technical Profile
- Reference Code
- REM145
- CAS Number
- 1809249-37-3
- Molecular Weight
- 602.58 g/mol
- Chemical Class
- N/A
- Molecular Formula
- C27H35N6O8P
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Remdesivir as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| No verified brands found for this salt. | ||||